Publication | Open Access

A randomised phase II study of the efficacy, safety and cost-effectiveness of pegfilgrastim and filgrastim after autologous stem cell transplant for lymphoma and myeloma (PALM study)

Lymphoid NeoplasiaCell TherapyTransplantationMarrow TransplantationPalm StudyMedicineStem Cell TransplantationSurgeryRadiation OncologyOncologyCell Transplantation